chrisvoncsefalvay/vaers-outcomes huggingface dataset:
He got his vaccine, just had a usual sore arm, did not feel it going in, didn't have any pain. His arm was not anything to complain about or sore and was not tired. On 11/3/21, his eye felt funny. He told his wife that he could not close his eye. He woke up the next morning and his face was drooping, mouth on one side was not moving, his eye was partially closed but could not close it. She did neuro checks on him, which he had equal bilateral grips. His pupils were equal and reactive to light and the lid was closing, and the left side of his mouth did not move at all. She asked him how he felt, and he had good grip and said that his arm hurt but just at the needle insertion. He said that it hurt behind his ear, and he took his hearing aide apart and complained that it was towards about the back of the head about 1 1/2" to where skull bone was and it hurt. He showed her where it hurt and thought he may have had a growth pushing it in, and took him to the ER. He was seen by Dr. in the ER and she insisted on an MRI. He was drooling and could not spit and had weakness. He felt that it looked like Bell's palsy due to lack of any other symptoms. He did have Bell's palsy 25 years ago after a dental procedure which lasted about 2 months and then disappeared, and his symptoms are resolving now. She continued to give him drops in his eyes to keep it moist. It is not totally resolved, but she is sure it will go away and he is able to eat now. Pain in the back of his head which is resolving as well. The symptoms were all on the side he received the vaccine on.
acute flu lasting 3 days followed by 1 day with lighter symptoms.  The 3 days included acute  pain,fatigues,sleepiness,chills, body aches . On day 2 about 28 hours after taking the vaccine I walked to the bathroom and fainted. I am 65 and have never fainted.
Developed Shingles; confirmed by biopsy by my dermatologist, Dr. My spouse, who was vaccinated on the same day, developed shingles 24 hours before me.   Treated with valacyclovir.
Patient reports pain, erythema, swelling and warmth at site. Treated with clindamycin 300mg 3 times a day for 10 days.
SORE ARM; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination.   The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of sore arm was not reported. This report was non-serious.
In late July, we traveled, and I got sick. I had cold like symptoms. Came home and I went to urgent care. Got a Covid rapid test and it was not positive. They gave me antibiotics. I could not shake what I had. I went to my regular doctor, and they did blood work, and it came back really high in antibodies. They thought my Covid test might have been positive, but we still don't know. After getting the steroids it cleared everything up and I have not had any symptoms since then.
The event was a company wide shot. Pt was not due for a JEV shot. Pt was screened incorrectly by staff who's role was screening patients to see what vaccines are due. Staff relayed wrong information to the vaccinator (Staff 2), which resulted in vaccinating the patient to another unnecessary dose of JEV. Pt did not have a adverse reaction to the 3rd dose of JEV.
Painful on injection site; Hot on injection site/Arm was warm; Itching on injection site; Swollen injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Painful on injection site), VACCINATION SITE WARMTH (Hot on injection site/Arm was warm), VACCINATION SITE PRURITUS (Itching on injection site) and VACCINATION SITE SWELLING (Swollen injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 026A21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy NOS. Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PAIN (Painful on injection site), VACCINATION SITE WARMTH (Hot on injection site/Arm was warm), VACCINATION SITE PRURITUS (Itching on injection site) and VACCINATION SITE SWELLING (Swollen injection site). At the time of the report, VACCINATION SITE PAIN (Painful on injection site), VACCINATION SITE WARMTH (Hot on injection site/Arm was warm), VACCINATION SITE PRURITUS (Itching on injection site) and VACCINATION SITE SWELLING (Swollen injection site) outcome was unknown.            Concomitant medications included medication for allergy and blood pressure (unspecified).  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the events was not applicable.
Sharp pain in lower back in the right side above the waist line, its a muscle pain and not going away. Physical therapy doesn't work. Pain was to much to bear, Prior to this I was able to walk. This happened sometime in June 2021.
Pt presented to office 1 wk after immunization with large (6in x 4in approx) area redness, swelling and warmth (L) arm. Per pt is improving. Instructed to use cold packs to area and return to office if gets worse.
This spontaneous report as received from a nurse practitioner refers to a 14 years old female patient. The patient was vaccinated with a 0.5ml dose 1 and a 0.5ml dose 2 of (Merck) VARIVAX (lot # and route not reported) on 08-MAR-1999 and 04-MAR-2008 respectively. No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patient went into the office with a rash that was identified as shingles. No treatment information was reported. The outcome of rash that was identified as shingles was reported as recovered on an unspecified date. The relatedness for rash that was identified as shingles was not provided for (Merck) VARIVAX. This is one of several reports received from the same source. Additional information has been requested.
Flu like symptoms left side neck pain, left shoulder and extremities for 1 week following injection
Large red mark on arm - 3 inches long and an inch wide. After 3 months it has not gotten any lighter in color, still very red.
COVID-19 virus test positive; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (COVID-19 virus test positive) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure (patient is on blood pressure medications) and Cholesterol (patient is on cholesterol medications). Concomitant products included CLOPIDOGREL BISULFATE (PLAVIX) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (COVID-19 virus test positive). At the time of the report, SARS-COV-2 TEST POSITIVE (COVID-19 virus test positive) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, SARS-CoV-2 test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No treatment information was provided. Concomitant medications also include   Blood pressure and cholesterol medications.   Reporter did not allow further contact
36 hrs after injection extreme fatigue began. while improving slightly it has continued for 18 days. went to ER but they could not find a reason to admit me. Still very weak. Need help but no one can; Still very weak.; This is a spontaneous report from a contactable consumer (patient). A 75-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EL9262), via an unspecified route of administration, administrated in left arm on 12Feb2021 13:30 (age at the time of vaccination 75-years-old), as a single dose for COVID-19 immunization at Hospital. The patient's medical history included copd, and coronary artery disease. The patient's concomitant medications included spiriva, plavix, avodart, atorvastatin, lipitor, linzess, breo, and levoxly. Patient did not have known allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 14Feb2021, the patient experienced 36 hrs after injection extreme fatigue began. while improving slightly it has continued for 18 days. went to ER but they could not find a reason to admit me. Still very weak. Need help but no one can provide, and Still very weak. On 18Feb2021, the patient underwent lab tests and procedures which included Nasal Swab, COVID-19: Negative. The adverse event result in Emergency room/department or urgent care. No treatment received for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. Upon follow-up (26Feb2021), age of the patient at the time of vaccination, lot number, date and time of vaccination, date of lab test and result, concomitant drugs, adverse event, and outcome was updated. The outcome of the event was not recovered. Information on the lot/batch number has been requested.  Follow-up#1 (26Feb2021): This is a spontaneous report from a contactable consumer. This consumer (patient) reported that, which included: age of the patient at the time of vaccination, lot number, date and time of vaccination, date of lab test and result, concomitant drugs, adverse event, and outcome was updated in narrative.  Follow-up#2 (06Mar2021): This is a spontaneous report from a contactable consumer. This consumer (patient) reported that: no new information was added.  No follow-up attempts are needed. No further information is expected.
Felt dizzy and my vision was out of focus, nausea, palpitations, felt like I was going to fell out
Fever, nausea, pain under left arm in armpit, diarrhea, headaches, aches.
Information has been received from an RN concerning a 12 month old female who on 3/5/01 was vaccinated with the 1st dose of MMRII. The pt was vaccinated SC, in the left lateral thigh. It was noted that at the time of vaccination, the pt had no illnesses, allergies, birth defects or medical conditions. On 3/6/01, the pt experienced conjunctivitis, fever, cough and runny nose ("Other Medical Events"). The nurse noted the pt required a doctor's office visit and was treated with antibiotics and eye drops. Subsequently, the pt recovered from conjunctivitis, fever, cough and runny nose. Additional information has been requested.
I woke up 8 days after getting the vaccine (no side effects until now) with a circular warm, swollen red patch on my arm. I do not have a fever, it is not itchy. No other symptoms.
Information has been received from a consumer concerning her 15 year old daughter who on 15-MAY-2007 was vaccinated with a first dose of GARDASIL. Concomitant therapy included doxycycline. Subsequently the patient experienced injection site reaction. On 16-Aug-2007 the patient received the second dose and approximately 3 weeks later noticed a hard and tender area at the site injection. Medical attention was not sought. The patient had not recovered. No product quality complaint was involved. Additional information has been requested.
Swelling and heat below injection site, patient described as a welt the size of an orange (diameter).
Pt stated that he became SOB, had chest tightness, and felt flushed.  He then became pale and diaphoretic.  SAO2 98% HR 103
This spontaneous report was received from a healthcare professional via company representative (Merck Replacement) regarding a patient of unknown age and gender. Information regarding the patient's medical history, drug reactions/allergies and concomitant medications were not provided. On an unknown date, the patient was administered the 1st dose in the series with GARDASIL 0.5 ml (lot# and expiry date unknown). On an unknown date, the patient was administered the 2nd dose in the series as GARDASIL 9 (dosing details, lot# and expiry date not known) and then the 3rd dose in the series as GARDASIL 9 (dosing details, lot# and expiry date not known) (unknown date). Wrong vaccine administration was considered. No adverse effects were reported. There was no product quality complaint (PQC) involved. Additional information has been requested.
Coudn't breath. Called 911. Was taken to  hospital. She stayed Hospitalized for 2days.
Information has been received from a 25 year old female, for the Pregnancy Registry for GARDASIL vaccine (yeast), concerning herself who in October 2007, was vaccinated with the first dose of GARDASIL vaccine (yeast) and in June 2008, was vaccinated with the second dose of GARDASIL vaccine (yeast). After taking the first shot of GARDASIL vaccine (yeast), the patient found out that she was pregnant. In approximately 2008 the patient delivered a male baby. Her son was born with pulmonary problems along with other health issues. The patient did not seek medical attention. No further information is available.
This case was reported by a pharmacist via call center representative and described the occurrence of joint pain in a 56-year-old female patient who received SHINGRIX for prophylaxis. On 5th July 2018, the patient received the 1st dose of SHINGRIX .5 ml. On 6th July 2018, 1 days after receiving SHINGRIX, the patient experienced joint pain and mobility decreased. On an unknown date, the outcome of the joint pain and mobility decreased were recovered/resolved. It was unknown if the reporter considered the joint pain and mobility decreased to be related to SHINGRIX. Additional details were provided as follows: After receiving SHINGRIX, the patient experienced joint pain and inability to lift her arms. The pharmacist was unsure how long these symptoms lasted, but they had resolved. The pharmacist did not have vaccine information for this adverse event.
periodic confusions; unable to eat; migraine; periodic fatigue; extreme nausea; periodic body ache; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (periodic confusions), FEEDING DISORDER (unable to eat), MIGRAINE (migraine), FATIGUE (periodic fatigue) and NAUSEA (extreme nausea) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M2A and 08B21-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced CONFUSIONAL STATE (periodic confusions), FEEDING DISORDER (unable to eat), MIGRAINE (migraine), FATIGUE (periodic fatigue), NAUSEA (extreme nausea) and MYALGIA (periodic body ache). At the time of the report, CONFUSIONAL STATE (periodic confusions), FEEDING DISORDER (unable to eat), MIGRAINE (migraine), FATIGUE (periodic fatigue), NAUSEA (extreme nausea) and MYALGIA (periodic body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The same symptoms started 30 min after receiving the second shot.  No concomitant medications were provided by reporter.  Patient undergoing therapy for cognitive decline which occurred (along with a host of other side effects).   This case was linked to MOD21-065091, MOD21-065092 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Follow up has NNI.; Sender's Comments:  MOD21-065091:Crosslinked: Same reporter MOD21-065092:Crosslinked: Same reporter
PFIZER 5/11 YEARS GIVEN TO A 14 YEAR OLD CLIENT
2/10 Wellness appointment. Pt received the dtap vaccine. Even though I reminder Dr he has Mitochondrial dysfunction. I said no to the MMR vaccine. Dr still pushed for the dtap vaccine anyways. Unfortunately I said yes to it, even though my gut flipped. 2/11/17 Pt woke up in the morning complaining about the pain around the shot area. Fell asleep at 6:40pm. Woke up at 8pm crying about stomach and knee pains. Also felt warm. Temp was 99.5. He settled off. Then about 15mins later same thing woke up crying about his knees.   Stayed up until about midnight and couldn't sleep. 2/12 All day pt looked run down. Started regressing with chewing on blankets. Mentioned several times his arm hurts where the shot was given. I could feel a stiff bump at the injection site. Turns out he has a large bruise in the injection area. Nighttime (around 1:30am) he had a 103.4 fever. Gave him Aleve (About 1 3/4 of a tsp since he falls in between with weight.) Used a cold face rag with ice packs to help bring down his temp. He stayed awake until 4ish. 2/13 Pt stayed home from school. He slept in until 7am. He was sluggish and 'little' all day. 2/14. 9:30pm and at 11:25pm waking up screaming, crying and moaning. Unable to tell me what's wrong. Violently kicking and twisting in his bed. Asked for water but didn't drink it. Has a slight cough. Stayed up from 11:25 until 2ish he didn't want to go back to bed. Still chewing on blankets. During these episodes. 2/15 am pt didn't want to go to school. (Which never happens) gave me a hard time to get dressed and then to go outside for the bus. He was also grunting unable to express himself. Making the same kind of noise when he was unable to speak as a toddler. He wasn't listening and acting out. Not normal behavior for pt. Pt came home from school moody, hiding from me and crying. I can't seam to help him. Anytime I get close he acts out in anger.  I took a  video of how he is behaving. Which again is not normal behavior for pt! 9:30pm woke up screaming and crying. He can't talk to us and say what's bothering him. Moaning noises with him mumbling. Just angry with kicking and swing his arms. Had to walk around with him in our arms. After about 20 minutes able to place him in the couch to sleep. Refuses to stay in his bed. This is not normal!
low grade fever, severe diarrhea 18NOV94 all day; stomach bloated-hard to touch; did not ear for 1 day; given APAp q 4 hrs; called ER 8-9PM 18NOV94;
Information has been received from a physician concerning a 22 week male who on 15-DEC-2007 (lot number 657673/0904U), 14-MAR-2008 (659917/0017X) and 27-MAY-2008 (660596/0211X) was vaccinated with the first, second and third dose of ROTATEQ 2ml oral respectively. Subsequently the patient developed rotavirus infection. The patient was hospitalized because of this infection on 18-FEB-2009 and was discharged on 20-FEB-2009. Serologic test of the stool was performed with no result reported. The patient was recovering at the time of reporting. No further information is available.
urticaria (welts), itching began approx 9 hrs p/vax; also began having jerky motions, shaking all over; 330AM very drowsy, sleepy p/jerky episodes;
TOOK 4 DOSES OF VIVOTIF THAT WAS UNREFRIGERATED FOR 2 DAYS; This spontaneous case report (PVX2019-2946) was received from a pharmacist on 02-Dec-2019. It described a consumer who "took four doses of Vivotif that was unrefrigerated for 2 days" (PT: Product storage error). She was receiving oral Vivotif for typhoid fever prophylaxis.  Case report: The consumer left Vivotif unrefrigerated for 2 days and then refrigerated afterwards. However, the consumer took all the doses from it. It was reported that this was happened last year.  Action taken with Vivotif with respect to the reported event was not applicable.  The clinical outcome of the event was unknown.  Company Comment: A consumer left Vivotif unrefrigerated for 2 days and then refrigerated it afterwards and completed the full course of Vivotif (Incorrect product storage). Considering the nature of the event, the causality of the event is assessed as not related to Vivotif.; Sender's Comments: A consumer left Vivotif unrefrigerated for 2 days and then refrigerated it afterwards and completed the full course of Vivotif (Incorrect product storage). Considering the nature of the event, the causality of the event is assessed as not related to Vivotif.
Pt states she had a shingles eruption all over her legs, about 25 blisters.
10/21/2014 Patient had been ill and having hives for several weeks prior to immunizations.
Patient developed rash, signs of stress breathing, tingling arm and legs, dry throat, high blood pressure after 3 mins of 1st moderna vaccine administration. - 911 was called and ambulance arrived within 10 mins of call - patient was assessed and observed for 30 mins by emt, symptoms improved and patient chose to return home for further observation from home.
Client reported abdominal cramping intermittently beginning 24 hours after receiving vaccination. Continues 2 days after.
On or about April 14, 2021 patient yelled out to a friend to come help him. Patient stated that he "could not see or move". The friend called the ambulance and patient was taken to hospital. One of the doctors tending to patient told me patient had several strokes (over 5). These strokes have left him blind and incapacitated.  He is still currently at hospital.
Patient received Pfizer COVID vaccine on 4/27/2021 and 5/18/2021. Patient arrived at vaccine POD on 1/22/2022 accompanying her daughter and inquired about receiving a booster for herself. Patient reported that after the 2nd dose of Pfizer, she experienced numbness and tingling in all extremities that started within 15min and lasted 2 weeks. She followed up with her provider but could not recall the response. Patient has no allergies, no medical conditions, and takes no medication. Patient was interested if it was better to get Moderna instead of Pfizer for her booster. Patient left vaccine site. PHN elevated medical consult to clinical leads at 1219. Dr approved Moderna booster with 30min observation period at 1230. PHN called patient to inform of medical approval at 1231, patient reported she would return a different day
Presented with low O2 sats at home.  Reports pos covid test 1 week pta.  Admitted with Coivd 19 infection and thrombocytopenia.  presented with generalized weakness and decreased appetite. She was found to be COVID-19 positive with evidence of pneumonia on CXR. Patient was started on empiric antibiotics and steroids. Patient was not hypoxic - saturating well on room air even with exertion. SNF and home health were offered however patient refused. Her main concern was cooking for herself and her husband. Therefore, information regarding meals and caregivers was given. Spoke with patient's granddaughter who will help care for patient at home. As patient is stable and fully independent.
Client states about 4o after shot his arm got red and swollen, warm to touch and hurt when he moved it. He stated he had temp of 100.8. Went to ER + got antibiotic + painkiller.
Pt arose fr bed 6APR91 w/purpura generalized over body & bruising; no other sx x/fatigue & malaise; Seen by MD; blood test showed dec plats; Hospitalization rec'd Gammaglobin in IV x 2;